These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27142783)

  • 1. Clinical research in neonates and infants: Challenges and perspectives.
    Coppini R; Simons SHP; Mugelli A; Allegaert K
    Pharmacol Res; 2016 Jun; 108():80-87. PubMed ID: 27142783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic use at a pediatric age.
    Kim DS; Park MS
    Yonsei Med J; 1998 Dec; 39(6):595-603. PubMed ID: 10097688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia.
    Läer S; Elshoff JP; Meibohm B; Weil J; Mir TS; Zhang W; Hulpke-Wette M
    J Am Coll Cardiol; 2005 Oct; 46(7):1322-30. PubMed ID: 16198851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracetamol and morphine for infant and neonatal pain; still a long way to go?
    Baarslag MA; Allegaert K; Van Den Anker JN; Knibbe CA; Van Dijk M; Simons SH; Tibboel D
    Expert Rev Clin Pharmacol; 2017 Jan; 10(1):111-126. PubMed ID: 27785937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria supporting the study of drugs in the newborn.
    Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
    Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular support in preterm infants.
    Evans JR; Lou Short B; Van Meurs K; Cheryl Sachs H
    Clin Ther; 2006 Sep; 28(9):1366-84. PubMed ID: 17062310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug policy in Europe Research and funding in neonates: current challenges, future perspectives, new opportunities.
    Jacqz-Aigrain E
    Early Hum Dev; 2011 Mar; 87 Suppl 1():S27-30. PubMed ID: 21269785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBPK in Preterm and Term Neonates: A Review.
    Michelet R; Bocxlaer JV; Vermeulen A
    Curr Pharm Des; 2017; 23(38):5943-5954. PubMed ID: 28990526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Rocchi F; Tomasi P
    Pharmacol Res; 2011 Sep; 64(3):169-75. PubMed ID: 21376810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.
    Chen Y; Lu J; Dong M; Wu D; Zhu Y; Li Q; Chen C; Li Z
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1479-1488. PubMed ID: 27644691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peculiarities of drug therapy in childhood].
    Reinhardt D; Kusenbach G
    Monatsschr Kinderheilkd; 1986 Nov; 134(11):772-8. PubMed ID: 3807917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.
    Cies JJ; Fugarolas KN; Moore WS; Mason RW; Menkiti OR
    Pharmacotherapy; 2017 Apr; 37(4):456-463. PubMed ID: 28226400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic considerations in the use of antivirals in neonates.
    Enioutina EY; Constance JE; Stockmann C; Linakis MW; Yu T; Rower JE; Balch AH; Sherwin CM
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1861-78. PubMed ID: 26535960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological research in pediatrics: From neonates to adolescents.
    Rakhmanina NY; van den Anker JN
    Adv Drug Deliv Rev; 2006 Apr; 58(1):4-14. PubMed ID: 16533543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates.
    Ward RM; Benjamin D; Barrett JS; Allegaert K; Portman R; Davis JM; Turner MA
    Pediatr Res; 2017 May; 81(5):692-711. PubMed ID: 28248319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing in neonates: special considerations in physiology and trial design.
    Ku LC; Smith PB
    Pediatr Res; 2015 Jan; 77(1-1):2-9. PubMed ID: 25268145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.